Citation Impact
Citing Papers
Recent Molecular Genetic Explorations of Caenorhabditis elegans MicroRNAs
2018 StandoutNobel
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
2010
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Initiating and Cancer-Propagating Cells in TEL-AML1 -Associated Childhood Leukemia
2008 Science
Leukemia in twins: lessons in natural history
2003
Evolution of the Cancer Stem Cell Model
2014 Standout
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
2019 StandoutNobel
Chromatin modifiers and the promise of epigenetic therapy in acute leukemia
2014
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34 + Hematopoietic Stem and Progenitor Cells
2017
Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies
2004
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
2020 StandoutNobel
Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study
2004
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
2015 Nature
Glutaminase activity determines cytotoxicity of l-asparaginases on most leukemia cell lines
2015
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Current management and challenges of malignant disease in the CNS in paediatric leukaemia
2008
IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity
2021
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Tumor heterogeneity: Causes and consequences
2009
The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms
2003
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Effective gene expression prediction from sequence by integrating long-range interactions
2021 StandoutNobel
cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation
2016
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Detecting genome-wide directional effects of transcription factor binding on polygenic disease risk
2018
Cancer immunotherapy via dendritic cells
2012 Standout
Cancer stem cells revisited
2017 Standout
Epigenetics in Cancer: A Hematological Perspective
2016
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Relapsed childhood acute lymphoblastic leukaemia
2013
Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues
2008
Environmental genotoxicants/carcinogens and childhood cancer: Bridgeable gaps in scientific knowledge
2006
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Exposure to pesticides and the associated human health effects
2016 Standout
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Novel Roles for MLH3 Deficiency and TLE6-Like Amplification in DNA Mismatch Repair-Deficient Gastrointestinal Tumorigenesis and Progression
2008 StandoutNobel
Regulation of cancer cell metabolism
2011 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Sickle-cell disease
2010 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase
2006
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
The runx genes: gain or loss of function in cancer
2005
The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer Cells
2014
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
MicroRNAs and developmental timing
2011 StandoutNobel
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
2014
Clonal evolution in cancer
2012 StandoutNature
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Defining trained immunity and its role in health and disease
2020 Standout
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Genetic variegation of clonal architecture and propagating cells in leukaemia
2010 Nature
Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch
2018
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
2008
Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
2011 Nature
The cancer genome
2009 StandoutNature
Histone deacetylases as targets for treatment of multiple diseases
2013
Role of Functional Imaging in the Management of Lymphoma
2011
Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase
2006
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
2011
Acute Myeloid Leukemia
2015 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
MicroRNA miR-125b causes leukemia
2010
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1
2012
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
2016 StandoutNobel
Chromosome translocations and covert leukemic clones are generated during normal fetal development
2002
MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets
2010
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Combination therapy in combating cancer
2017 Standout
Residential pesticides and childhood leukemia: a systematic review and meta-analysis
2011
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
2015
Customizing the genome as therapy for the β-hemoglobinopathies
2016
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Cancer Genome Landscapes
2013 StandoutScience
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
2008 Science
Asparagine Synthetase Chemotherapy
2006
Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
2011
Protein Modification by SUMO
2004 Standout
Does BCR /ABL 1 positive Acute Myeloid Leukaemia Exist?
2013
MicroRNA s play a central role in molecular dysfunctions linking inflammation with cancer
2013
Multiple Myeloma
2011 Standout
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
2018
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
2018 Science
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Jan Trka being referenced
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group
2007
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia
2009
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
2004
Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase
2012
Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically
2012
Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells
2015
TEL/AML1 positivity in childhood ALL: average or better prognosis?
1999
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
2010
Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring
2005
B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL
2008
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
2007
Pre-natal, Clonal Origin of Acute Lymphoblastic Leukaemia in Triplets
2003
Prenatal origin of childhood AML occurs less frequently than in childhood ALL
2006
Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia
2006
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
2009
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern
2013
Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells
2004
Acute lymphoblastic leukemia incidence during socioeconomic transition: selective increase in children from 1 to 4 years
2002
Childhood secondary ALL after ALL treatment
2007
IKZF1 status as a prognostic feature in BCR-ABL1–positive childhood ALL
2013
No Evidence for MLL/AF4 Expression in Normal Cord Blood Samples
1999
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
2011
No Evidence for MLL/AF4 Expression in Normal Cord Blood Samples
1999
Lymphoid Differentiation Pathways Can Be Traced by TCR δ Rearrangements
2005
Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia
2000
BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations
2015
TEL Deletion Analysis Supports a Novel View of Relapse in Childhood Acute Lymphoblastic Leukemia
2004
Detectable Minimal Residual Disease before Haematopoietic Stem Cell Transplantation Predicts Extremely Poor Prognosis in Children with Acute Lymphoblastic Leukaemia.
2005
Wilms’ Tumor 1 Gene Mutations in Childhood Acute Myeloid Leukemia: A New Prognostic factor with Implications for MRD Detection
2008
Acute lymphoblastic leukemia incidence during socioeconomic transition: selective increase in children from 1 to 4 years
2002